 Nancy Krebs
Concepts (707)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zinc | 109 | 2024 | 291 | 16.220 |
Why?
| | Infant Nutritional Physiological Phenomena | 40 | 2025 | 140 | 9.650 |
Why?
| | Dietary Supplements | 54 | 2025 | 533 | 7.740 |
Why?
| | Nutritional Status | 41 | 2024 | 325 | 6.220 |
Why?
| | Milk, Human | 33 | 2023 | 145 | 5.880 |
Why?
| | Developing Countries | 76 | 2025 | 278 | 5.800 |
Why?
| | Breast Feeding | 51 | 2024 | 423 | 5.610 |
Why?
| | Maternal Nutritional Physiological Phenomena | 15 | 2024 | 168 | 5.280 |
Why?
| | Diet | 61 | 2025 | 1205 | 5.240 |
Why?
| | Micronutrients | 22 | 2024 | 84 | 5.070 |
Why?
| | Infant Food | 25 | 2025 | 66 | 4.350 |
Why?
| | Intestinal Absorption | 37 | 2022 | 98 | 4.160 |
Why?
| | Meat | 13 | 2021 | 92 | 4.110 |
Why?
| | Infant | 152 | 2025 | 8994 | 3.660 |
Why?
| | Child Development | 21 | 2024 | 451 | 3.650 |
Why?
| | Premature Birth | 23 | 2023 | 313 | 3.470 |
Why?
| | Pregnancy Outcome | 30 | 2024 | 379 | 3.360 |
Why?
| | Iron | 19 | 2023 | 285 | 3.350 |
Why?
| | Nutritional Requirements | 25 | 2019 | 76 | 3.270 |
Why?
| | Infant Mortality | 36 | 2023 | 97 | 3.100 |
Why?
| | Infant, Newborn | 115 | 2025 | 5704 | 3.060 |
Why?
| | Preconception Care | 11 | 2025 | 39 | 3.000 |
Why?
| | Pregnancy | 129 | 2025 | 6247 | 2.950 |
Why?
| | Phytic Acid | 19 | 2017 | 43 | 2.880 |
Why?
| | Growth Disorders | 12 | 2022 | 78 | 2.660 |
Why?
| | Iron, Dietary | 9 | 2019 | 21 | 2.530 |
Why?
| | Infant Formula | 11 | 2023 | 75 | 2.450 |
Why?
| | Anemia, Iron-Deficiency | 9 | 2022 | 58 | 2.410 |
Why?
| | Perinatal Death | 13 | 2023 | 22 | 2.410 |
Why?
| | Guatemala | 37 | 2024 | 310 | 2.370 |
Why?
| | Stillbirth | 25 | 2023 | 59 | 2.370 |
Why?
| | Child Health | 20 | 2023 | 145 | 2.330 |
Why?
| | Female | 256 | 2025 | 68162 | 2.230 |
Why?
| | Prenatal Care | 23 | 2025 | 272 | 2.230 |
Why?
| | Food, Fortified | 18 | 2023 | 37 | 2.170 |
Why?
| | Poverty | 13 | 2023 | 492 | 2.120 |
Why?
| | Humans | 332 | 2025 | 128896 | 2.080 |
Why?
| | Obesity, Morbid | 7 | 2021 | 241 | 2.030 |
Why?
| | Obesity | 24 | 2024 | 2844 | 1.910 |
Why?
| | Homeostasis | 21 | 2015 | 604 | 1.910 |
Why?
| | Dairy Products | 3 | 2021 | 35 | 1.910 |
Why?
| | Cesarean Section | 8 | 2021 | 180 | 1.890 |
Why?
| | Infant Health | 10 | 2023 | 24 | 1.870 |
Why?
| | Lactation | 15 | 2024 | 168 | 1.850 |
Why?
| | Body Mass Index | 23 | 2023 | 2244 | 1.800 |
Why?
| | Fetal Development | 6 | 2025 | 283 | 1.790 |
Why?
| | Pakistan | 31 | 2024 | 75 | 1.780 |
Why?
| | Feces | 25 | 2023 | 430 | 1.760 |
Why?
| | Gastric Bypass | 6 | 2019 | 106 | 1.740 |
Why?
| | Trace Elements | 13 | 2022 | 46 | 1.700 |
Why?
| | Delivery, Obstetric | 19 | 2025 | 133 | 1.690 |
Why?
| | Mothers | 13 | 2024 | 723 | 1.610 |
Why?
| | Maternal Mortality | 18 | 2025 | 40 | 1.540 |
Why?
| | Pregnancy Complications | 16 | 2024 | 487 | 1.520 |
Why?
| | Dietary Proteins | 10 | 2025 | 131 | 1.510 |
Why?
| | Birth Weight | 22 | 2024 | 493 | 1.500 |
Why?
| | Energy Intake | 11 | 2025 | 453 | 1.410 |
Why?
| | Infant, Small for Gestational Age | 6 | 2021 | 83 | 1.400 |
Why?
| | Growth | 7 | 2020 | 57 | 1.350 |
Why?
| | Maternal Health | 6 | 2023 | 45 | 1.310 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2025 | 334 | 1.310 |
Why?
| | Zea mays | 12 | 2017 | 41 | 1.280 |
Why?
| | Infant, Premature | 9 | 2023 | 540 | 1.270 |
Why?
| | Adult | 110 | 2025 | 35361 | 1.270 |
Why?
| | Anthropometry | 13 | 2024 | 205 | 1.270 |
Why?
| | Gastrointestinal Microbiome | 8 | 2025 | 635 | 1.250 |
Why?
| | Child | 71 | 2024 | 20824 | 1.230 |
Why?
| | Gastrectomy | 3 | 2021 | 99 | 1.220 |
Why?
| | Gestational Age | 15 | 2023 | 857 | 1.200 |
Why?
| | Zinc Isotopes | 22 | 2011 | 22 | 1.200 |
Why?
| | Child, Preschool | 51 | 2024 | 10457 | 1.200 |
Why?
| | Child Nutritional Physiological Phenomena | 9 | 2019 | 105 | 1.190 |
Why?
| | Rural Population | 18 | 2022 | 504 | 1.170 |
Why?
| | Malnutrition | 4 | 2023 | 78 | 1.160 |
Why?
| | Feeding Behavior | 12 | 2023 | 620 | 1.130 |
Why?
| | Infant, Low Birth Weight | 13 | 2024 | 134 | 1.120 |
Why?
| | Pre-Eclampsia | 5 | 2023 | 183 | 1.120 |
Why?
| | Prospective Studies | 49 | 2024 | 7060 | 1.090 |
Why?
| | Biological Availability | 22 | 2022 | 129 | 1.080 |
Why?
| | Registries | 27 | 2023 | 1916 | 1.050 |
Why?
| | Nutritional Sciences | 5 | 2019 | 42 | 1.030 |
Why?
| | Nutrition Assessment | 4 | 2017 | 85 | 1.030 |
Why?
| | Zambia | 18 | 2024 | 55 | 1.020 |
Why?
| | Biomarkers | 21 | 2024 | 3874 | 1.010 |
Why?
| | Male | 116 | 2025 | 63146 | 1.000 |
Why?
| | Food | 3 | 2020 | 169 | 1.000 |
Why?
| | Body Composition | 9 | 2023 | 654 | 0.990 |
Why?
| | Anemia | 7 | 2025 | 155 | 0.990 |
Why?
| | Azithromycin | 6 | 2025 | 92 | 0.980 |
Why?
| | Weaning | 6 | 2024 | 49 | 0.940 |
Why?
| | Birth Intervals | 2 | 2021 | 20 | 0.920 |
Why?
| | Perinatal Mortality | 10 | 2022 | 12 | 0.920 |
Why?
| | Vaginal Birth after Cesarean | 2 | 2021 | 25 | 0.910 |
Why?
| | Young Adult | 50 | 2024 | 12286 | 0.870 |
Why?
| | Postpartum Period | 6 | 2024 | 332 | 0.870 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 74 | 0.870 |
Why?
| | India | 16 | 2024 | 167 | 0.860 |
Why?
| | Premenopause | 3 | 2021 | 126 | 0.850 |
Why?
| | Democratic Republic of the Congo | 13 | 2024 | 25 | 0.830 |
Why?
| | Anastomosis, Roux-en-Y | 2 | 2021 | 27 | 0.830 |
Why?
| | Education, Medical | 4 | 2019 | 241 | 0.830 |
Why?
| | Maternal Health Services | 6 | 2019 | 93 | 0.830 |
Why?
| | Powders | 9 | 2022 | 42 | 0.820 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2021 | 33 | 0.800 |
Why?
| | Double-Blind Method | 18 | 2025 | 1858 | 0.790 |
Why?
| | Obstetric Labor Complications | 6 | 2020 | 30 | 0.790 |
Why?
| | Overweight | 7 | 2023 | 522 | 0.790 |
Why?
| | Inflammation | 6 | 2022 | 2694 | 0.790 |
Why?
| | Women's Health | 13 | 2023 | 361 | 0.780 |
Why?
| | Vegetables | 2 | 2022 | 146 | 0.780 |
Why?
| | Vitamins | 3 | 2023 | 171 | 0.770 |
Why?
| | Edible Grain | 7 | 2014 | 48 | 0.760 |
Why?
| | Cesarean Section, Repeat | 1 | 2021 | 11 | 0.750 |
Why?
| | Weight Reduction Programs | 2 | 2013 | 107 | 0.750 |
Why?
| | Body Height | 6 | 2022 | 191 | 0.730 |
Why?
| | Nutritive Value | 3 | 2024 | 36 | 0.720 |
Why?
| | Models, Biological | 9 | 2016 | 1702 | 0.710 |
Why?
| | Pregnant Women | 6 | 2023 | 126 | 0.700 |
Why?
| | Deficiency Diseases | 6 | 2019 | 9 | 0.690 |
Why?
| | Weight Gain | 8 | 2023 | 504 | 0.690 |
Why?
| | Ultrasonography, Prenatal | 6 | 2020 | 266 | 0.670 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 11 | 0.670 |
Why?
| | Milk Banks | 1 | 2019 | 1 | 0.670 |
Why?
| | Recommended Dietary Allowances | 3 | 2018 | 19 | 0.670 |
Why?
| | Health Education | 4 | 2018 | 324 | 0.660 |
Why?
| | Adolescent | 46 | 2023 | 20197 | 0.650 |
Why?
| | Malabsorption Syndromes | 1 | 2019 | 16 | 0.650 |
Why?
| | Dietary Fats | 2 | 2020 | 302 | 0.640 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2019 | 9 | 0.640 |
Why?
| | Iron Metabolism Disorders | 2 | 2015 | 4 | 0.630 |
Why?
| | Maternal Death | 4 | 2020 | 10 | 0.630 |
Why?
| | Developed Countries | 2 | 2015 | 33 | 0.630 |
Why?
| | Metabolomics | 2 | 2021 | 592 | 0.620 |
Why?
| | Malaria | 1 | 2019 | 51 | 0.610 |
Why?
| | Longitudinal Studies | 19 | 2023 | 2668 | 0.610 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.610 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 319 | 0.600 |
Why?
| | Nutrition Therapy | 2 | 2019 | 31 | 0.600 |
Why?
| | Avitaminosis | 1 | 2018 | 7 | 0.600 |
Why?
| | Parity | 8 | 2023 | 120 | 0.590 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 520 | 0.590 |
Why?
| | Sepsis | 4 | 2025 | 561 | 0.580 |
Why?
| | Enteritis | 1 | 2019 | 95 | 0.580 |
Why?
| | Kenya | 11 | 2024 | 105 | 0.580 |
Why?
| | Body Size | 6 | 2019 | 102 | 0.570 |
Why?
| | Weight Loss | 2 | 2013 | 723 | 0.570 |
Why?
| | Hemoglobins | 6 | 2021 | 343 | 0.560 |
Why?
| | Anti-Bacterial Agents | 5 | 2025 | 1701 | 0.560 |
Why?
| | Bangladesh | 7 | 2024 | 42 | 0.560 |
Why?
| | Diarrhea | 5 | 2022 | 179 | 0.560 |
Why?
| | Insulin | 7 | 2021 | 2311 | 0.560 |
Why?
| | Body Weight | 13 | 2019 | 931 | 0.550 |
Why?
| | Metabolome | 1 | 2020 | 316 | 0.540 |
Why?
| | Leptin | 5 | 2018 | 217 | 0.520 |
Why?
| | Vitamin E | 1 | 2016 | 118 | 0.520 |
Why?
| | Prevalence | 12 | 2024 | 2540 | 0.510 |
Why?
| | Child Nutrition Sciences | 1 | 2015 | 7 | 0.500 |
Why?
| | Global Health | 9 | 2021 | 317 | 0.480 |
Why?
| | Cross-Sectional Studies | 25 | 2023 | 5032 | 0.480 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 5 | 0.480 |
Why?
| | Starch | 1 | 2015 | 22 | 0.480 |
Why?
| | Pregnancy Trimester, First | 7 | 2023 | 133 | 0.480 |
Why?
| | Brain | 2 | 2017 | 2592 | 0.480 |
Why?
| | Nutrition Policy | 6 | 2017 | 56 | 0.470 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2024 | 59 | 0.470 |
Why?
| | Cohort Studies | 14 | 2021 | 5394 | 0.460 |
Why?
| | Aging | 6 | 2018 | 1767 | 0.460 |
Why?
| | Calcium | 5 | 2022 | 1173 | 0.460 |
Why?
| | Health Promotion | 4 | 2023 | 712 | 0.460 |
Why?
| | Infant, Premature, Diseases | 1 | 2015 | 95 | 0.450 |
Why?
| | Age Factors | 9 | 2015 | 3133 | 0.450 |
Why?
| | Adiposity | 3 | 2018 | 505 | 0.440 |
Why?
| | Socioeconomic Factors | 13 | 2024 | 1192 | 0.440 |
Why?
| | Pediatrics | 6 | 2018 | 1060 | 0.440 |
Why?
| | Risk Factors | 25 | 2023 | 9792 | 0.440 |
Why?
| | Educational Status | 11 | 2022 | 458 | 0.430 |
Why?
| | Calcium, Dietary | 5 | 2022 | 55 | 0.430 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 27 | 0.430 |
Why?
| | Income | 9 | 2023 | 191 | 0.420 |
Why?
| | Regression Analysis | 10 | 2016 | 987 | 0.420 |
Why?
| | Dysprosium | 2 | 2010 | 2 | 0.420 |
Why?
| | Aspirin | 6 | 2024 | 379 | 0.410 |
Why?
| | Randomized Controlled Trials as Topic | 9 | 2025 | 1366 | 0.410 |
Why?
| | Neurodevelopmental Disorders | 3 | 2023 | 151 | 0.410 |
Why?
| | Antioxidants | 1 | 2016 | 557 | 0.410 |
Why?
| | Flour | 4 | 2015 | 6 | 0.400 |
Why?
| | Hypertension, Pregnancy-Induced | 2 | 2023 | 67 | 0.400 |
Why?
| | Occupational Health Services | 1 | 2012 | 32 | 0.400 |
Why?
| | Pregnancy Trimester, Third | 3 | 2017 | 105 | 0.400 |
Why?
| | Intestinal Mucosa | 7 | 2018 | 569 | 0.390 |
Why?
| | Triticum | 2 | 2009 | 12 | 0.390 |
Why?
| | Metagenome | 1 | 2013 | 137 | 0.390 |
Why?
| | Heme | 1 | 2012 | 77 | 0.390 |
Why?
| | Dietary Carbohydrates | 2 | 2010 | 151 | 0.380 |
Why?
| | Glucocorticoids | 4 | 2016 | 570 | 0.380 |
Why?
| | Protein Hydrolysates | 2 | 2002 | 7 | 0.380 |
Why?
| | Caseins | 2 | 2002 | 18 | 0.380 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2021 | 308 | 0.380 |
Why?
| | Maternal Age | 12 | 2020 | 121 | 0.370 |
Why?
| | Social Class | 3 | 2022 | 256 | 0.370 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 182 | 0.350 |
Why?
| | Labor, Obstetric | 2 | 2021 | 55 | 0.350 |
Why?
| | Workplace | 1 | 2012 | 246 | 0.350 |
Why?
| | Maternal-Child Health Services | 3 | 2019 | 12 | 0.340 |
Why?
| | Wasting Syndrome | 1 | 2010 | 11 | 0.340 |
Why?
| | Failure to Thrive | 3 | 2009 | 29 | 0.340 |
Why?
| | Plant Preparations | 1 | 2010 | 31 | 0.340 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2013 | 0.340 |
Why?
| | Biological Transport | 3 | 2021 | 394 | 0.340 |
Why?
| | Time Factors | 9 | 2021 | 6568 | 0.330 |
Why?
| | Nutritional Physiological Phenomena | 4 | 2022 | 52 | 0.330 |
Why?
| | Nutrition Surveys | 1 | 2011 | 259 | 0.320 |
Why?
| | Absorption | 11 | 2013 | 56 | 0.320 |
Why?
| | Quality Indicators, Health Care | 1 | 2012 | 299 | 0.320 |
Why?
| | Lipids | 2 | 2024 | 614 | 0.310 |
Why?
| | Staining and Labeling | 1 | 2009 | 142 | 0.310 |
Why?
| | Fetus | 4 | 2021 | 764 | 0.310 |
Why?
| | Medically Underserved Area | 3 | 2018 | 82 | 0.310 |
Why?
| | Patient Safety | 1 | 2012 | 292 | 0.300 |
Why?
| | Cross-Over Studies | 6 | 2020 | 513 | 0.300 |
Why?
| | Diet Records | 5 | 2014 | 78 | 0.300 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.300 |
Why?
| | Seafood | 2 | 2025 | 26 | 0.300 |
Why?
| | Practice Guidelines as Topic | 4 | 2016 | 1523 | 0.290 |
Why?
| | Logistic Models | 4 | 2021 | 1963 | 0.290 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2023 | 1264 | 0.280 |
Why?
| | Antibiotic Prophylaxis | 2 | 2025 | 104 | 0.280 |
Why?
| | Pediatric Obesity | 3 | 2023 | 568 | 0.270 |
Why?
| | Cytokines | 3 | 2021 | 1995 | 0.270 |
Why?
| | Urinalysis | 5 | 2020 | 70 | 0.270 |
Why?
| | Administration, Oral | 7 | 2023 | 783 | 0.270 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 306 | 0.270 |
Why?
| | Referral and Consultation | 3 | 2019 | 727 | 0.270 |
Why?
| | Adiponectin | 2 | 2018 | 232 | 0.270 |
Why?
| | Communicable Diseases | 2 | 2023 | 141 | 0.260 |
Why?
| | Follow-Up Studies | 7 | 2024 | 4917 | 0.260 |
Why?
| | Health Personnel | 3 | 2023 | 642 | 0.260 |
Why?
| | Folic Acid | 3 | 2023 | 182 | 0.250 |
Why?
| | Cause of Death | 2 | 2018 | 392 | 0.250 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Internship and Residency | 2 | 2019 | 1052 | 0.240 |
Why?
| | Risk Assessment | 7 | 2018 | 3286 | 0.240 |
Why?
| | Bone and Bones | 2 | 2019 | 297 | 0.240 |
Why?
| | Colorado | 7 | 2017 | 4443 | 0.240 |
Why?
| | Schools, Medical | 1 | 2006 | 128 | 0.240 |
Why?
| | Environment | 2 | 2017 | 346 | 0.240 |
Why?
| | Perinatal Care | 2 | 2018 | 54 | 0.240 |
Why?
| | Feasibility Studies | 4 | 2023 | 859 | 0.230 |
Why?
| | Retrospective Studies | 9 | 2023 | 14546 | 0.230 |
Why?
| | Parents | 1 | 2013 | 1301 | 0.230 |
Why?
| | Maternal Welfare | 2 | 2014 | 19 | 0.230 |
Why?
| | Agaricus | 1 | 2023 | 2 | 0.220 |
Why?
| | Erythrocytes | 5 | 2022 | 667 | 0.220 |
Why?
| | China | 5 | 2014 | 187 | 0.220 |
Why?
| | Asia | 6 | 2020 | 58 | 0.220 |
Why?
| | Reference Values | 4 | 2022 | 791 | 0.210 |
Why?
| | Ferritins | 2 | 2016 | 58 | 0.210 |
Why?
| | Folic Acid Deficiency | 1 | 2023 | 48 | 0.210 |
Why?
| | Soybean Proteins | 1 | 2002 | 14 | 0.210 |
Why?
| | Vitamin K | 1 | 2023 | 42 | 0.210 |
Why?
| | Milk | 3 | 2018 | 129 | 0.210 |
Why?
| | Food Assistance | 1 | 2023 | 29 | 0.210 |
Why?
| | Vitamin A | 1 | 2023 | 55 | 0.210 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2002 | 23 | 0.210 |
Why?
| | Plant Oils | 1 | 2002 | 29 | 0.210 |
Why?
| | Faculty, Medical | 1 | 2006 | 263 | 0.210 |
Why?
| | Labor Presentation | 2 | 2019 | 2 | 0.210 |
Why?
| | Pandemics | 4 | 2024 | 1516 | 0.200 |
Why?
| | Temperature | 2 | 2023 | 634 | 0.200 |
Why?
| | Infant Care | 2 | 2015 | 46 | 0.200 |
Why?
| | Parenteral Nutrition | 1 | 2024 | 108 | 0.200 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2023 | 105 | 0.200 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2020 | 544 | 0.200 |
Why?
| | Health Facilities | 2 | 2020 | 80 | 0.200 |
Why?
| | Oryza | 1 | 2022 | 30 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2019 | 1968 | 0.200 |
Why?
| | United States | 14 | 2023 | 13975 | 0.200 |
Why?
| | Midwifery | 3 | 2014 | 47 | 0.200 |
Why?
| | Puerperal Infection | 3 | 2024 | 5 | 0.200 |
Why?
| | Fatty Acids | 3 | 2022 | 415 | 0.200 |
Why?
| | Postnatal Care | 2 | 2020 | 71 | 0.190 |
Why?
| | Enteral Nutrition | 1 | 2024 | 186 | 0.190 |
Why?
| | Africa | 5 | 2023 | 96 | 0.190 |
Why?
| | Adolescent Health | 2 | 2019 | 39 | 0.190 |
Why?
| | Biomedical Research | 3 | 2017 | 654 | 0.190 |
Why?
| | Adrenal Cortex Hormones | 2 | 2016 | 525 | 0.190 |
Why?
| | Intestinal Diseases | 1 | 2022 | 35 | 0.190 |
Why?
| | Students | 1 | 2007 | 576 | 0.190 |
Why?
| | Rural Health | 5 | 2016 | 70 | 0.190 |
Why?
| | Zinc Oxide | 3 | 2012 | 9 | 0.190 |
Why?
| | Tobacco, Smokeless | 1 | 2021 | 10 | 0.190 |
Why?
| | Patient Dropouts | 2 | 2012 | 65 | 0.190 |
Why?
| | Bone Density | 3 | 2006 | 470 | 0.190 |
Why?
| | Public Health | 3 | 2020 | 493 | 0.190 |
Why?
| | Tablets | 4 | 2022 | 39 | 0.190 |
Why?
| | Iodine | 1 | 2021 | 21 | 0.180 |
Why?
| | Cystic Fibrosis | 3 | 2000 | 1061 | 0.180 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 12 | 0.180 |
Why?
| | Isoleucine | 1 | 2021 | 13 | 0.180 |
Why?
| | Birth Rate | 1 | 2020 | 24 | 0.180 |
Why?
| | Animals | 16 | 2025 | 34628 | 0.180 |
Why?
| | Selenoproteins | 1 | 2020 | 8 | 0.180 |
Why?
| | Treatment Outcome | 5 | 2018 | 10239 | 0.180 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 5355 | 0.180 |
Why?
| | Phenylalanine | 1 | 2021 | 60 | 0.180 |
Why?
| | Valine | 1 | 2021 | 78 | 0.180 |
Why?
| | Carnitine | 1 | 2021 | 75 | 0.180 |
Why?
| | Digestive System Physiological Phenomena | 1 | 2000 | 4 | 0.170 |
Why?
| | Cleft Lip | 1 | 2020 | 42 | 0.170 |
Why?
| | Hyperinsulinism | 1 | 2021 | 119 | 0.170 |
Why?
| | Leucine | 1 | 2021 | 106 | 0.170 |
Why?
| | Parturition | 1 | 2021 | 66 | 0.170 |
Why?
| | Quality of Health Care | 3 | 2020 | 610 | 0.170 |
Why?
| | Oligohydramnios | 1 | 2020 | 11 | 0.170 |
Why?
| | Cleft Palate | 1 | 2020 | 63 | 0.170 |
Why?
| | Spouses | 1 | 2021 | 97 | 0.170 |
Why?
| | Biotransformation | 1 | 2020 | 48 | 0.170 |
Why?
| | Pasteurization | 1 | 2019 | 1 | 0.170 |
Why?
| | Digestion | 2 | 2017 | 8 | 0.170 |
Why?
| | Linear Models | 4 | 2016 | 817 | 0.170 |
Why?
| | International Classification of Diseases | 1 | 2020 | 124 | 0.170 |
Why?
| | Liver | 6 | 2020 | 1832 | 0.170 |
Why?
| | Thinness | 2 | 2018 | 89 | 0.170 |
Why?
| | Endotoxemia | 1 | 2020 | 95 | 0.170 |
Why?
| | Latin America | 5 | 2018 | 83 | 0.170 |
Why?
| | Pilot Projects | 3 | 2023 | 1545 | 0.160 |
Why?
| | Lactulose | 1 | 2019 | 1 | 0.160 |
Why?
| | Diet, Fat-Restricted | 1 | 2000 | 79 | 0.160 |
Why?
| | Polyhydramnios | 1 | 2019 | 17 | 0.160 |
Why?
| | Calorimetry | 1 | 2019 | 66 | 0.160 |
Why?
| | Health Resources | 1 | 2020 | 121 | 0.160 |
Why?
| | Mannitol | 1 | 2019 | 35 | 0.160 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 273 | 0.160 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 165 | 0.160 |
Why?
| | Intestines | 3 | 2019 | 346 | 0.160 |
Why?
| | Cholesterol, HDL | 2 | 2023 | 203 | 0.160 |
Why?
| | Hepcidins | 1 | 2019 | 21 | 0.160 |
Why?
| | Endemic Diseases | 1 | 2019 | 31 | 0.160 |
Why?
| | Malawi | 4 | 2015 | 47 | 0.150 |
Why?
| | Exercise | 7 | 2023 | 1923 | 0.150 |
Why?
| | Hypersensitivity, Immediate | 1 | 2019 | 48 | 0.150 |
Why?
| | Beverages | 4 | 2019 | 67 | 0.150 |
Why?
| | Species Specificity | 1 | 2020 | 566 | 0.150 |
Why?
| | Ghrelin | 1 | 2018 | 33 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 189 | 0.150 |
Why?
| | Oxidative Stress | 2 | 2017 | 1220 | 0.150 |
Why?
| | Postoperative Complications | 2 | 2009 | 2494 | 0.150 |
Why?
| | Blood Urea Nitrogen | 1 | 2018 | 52 | 0.150 |
Why?
| | Glucose | 3 | 2023 | 976 | 0.150 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 39 | 0.150 |
Why?
| | Adolescent Development | 1 | 2019 | 82 | 0.150 |
Why?
| | Middle Aged | 9 | 2025 | 30977 | 0.150 |
Why?
| | Meat Products | 2 | 2012 | 25 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 379 | 0.150 |
Why?
| | Erythrocyte Indices | 2 | 2021 | 27 | 0.150 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 484 | 0.150 |
Why?
| | Zika Virus Infection | 1 | 2019 | 101 | 0.150 |
Why?
| | Clostridium | 1 | 2017 | 14 | 0.140 |
Why?
| | Bifidobacterium | 1 | 2017 | 21 | 0.140 |
Why?
| | Proteobacteria | 1 | 2017 | 16 | 0.140 |
Why?
| | Food Supply | 1 | 2018 | 72 | 0.140 |
Why?
| | Social Determinants of Health | 1 | 2020 | 214 | 0.140 |
Why?
| | Indians, Central American | 1 | 2017 | 5 | 0.140 |
Why?
| | Cluster Analysis | 5 | 2019 | 479 | 0.140 |
Why?
| | Head | 2 | 2010 | 96 | 0.140 |
Why?
| | Communication | 1 | 2023 | 839 | 0.140 |
Why?
| | Infusions, Intravenous | 3 | 2006 | 395 | 0.140 |
Why?
| | Appetite | 2 | 2010 | 57 | 0.140 |
Why?
| | Isotopes | 1 | 2017 | 27 | 0.140 |
Why?
| | Guidelines as Topic | 1 | 2019 | 259 | 0.140 |
Why?
| | Vaccines | 1 | 2022 | 403 | 0.140 |
Why?
| | Copper | 3 | 2004 | 108 | 0.140 |
Why?
| | Food Analysis | 2 | 2015 | 20 | 0.140 |
Why?
| | Professional-Family Relations | 1 | 2018 | 144 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 48 | 0.130 |
Why?
| | Africa South of the Sahara | 4 | 2018 | 38 | 0.130 |
Why?
| | Biomedical Technology | 1 | 2017 | 39 | 0.130 |
Why?
| | Dietary Sucrose | 1 | 2016 | 47 | 0.130 |
Why?
| | Population Surveillance | 4 | 2020 | 428 | 0.130 |
Why?
| | Gene Expression | 1 | 2021 | 1476 | 0.130 |
Why?
| | Intensive Care, Neonatal | 1 | 2016 | 41 | 0.130 |
Why?
| | Interleukin-8 | 1 | 2017 | 261 | 0.130 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 93 | 0.130 |
Why?
| | Down-Regulation | 1 | 2018 | 637 | 0.130 |
Why?
| | Blood Pressure | 2 | 2020 | 1743 | 0.130 |
Why?
| | Spectrophotometry, Atomic | 8 | 2013 | 13 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3042 | 0.120 |
Why?
| | Ethiopia | 4 | 2009 | 35 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 138 | 0.120 |
Why?
| | Insulin Resistance | 2 | 2021 | 1163 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 255 | 0.120 |
Why?
| | Vitamin B 12 | 2 | 2023 | 120 | 0.120 |
Why?
| | Diabetes Mellitus | 4 | 2016 | 991 | 0.120 |
Why?
| | Overnutrition | 1 | 2015 | 30 | 0.120 |
Why?
| | Haemophilus influenzae type b | 1 | 2014 | 10 | 0.120 |
Why?
| | Data Accuracy | 1 | 2015 | 59 | 0.120 |
Why?
| | American Heart Association | 1 | 2016 | 311 | 0.120 |
Why?
| | Bacterial Capsules | 1 | 2014 | 28 | 0.120 |
Why?
| | Haemophilus Vaccines | 1 | 2014 | 28 | 0.120 |
Why?
| | Antibody Affinity | 1 | 2014 | 58 | 0.120 |
Why?
| | World Health Organization | 3 | 2012 | 106 | 0.120 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 212 | 0.120 |
Why?
| | Placenta | 1 | 2021 | 706 | 0.120 |
Why?
| | Drug Utilization | 3 | 2024 | 169 | 0.120 |
Why?
| | Stroke | 1 | 2023 | 1111 | 0.120 |
Why?
| | Contraception Behavior | 1 | 2015 | 91 | 0.120 |
Why?
| | Chile | 2 | 2012 | 18 | 0.120 |
Why?
| | Pregnancy in Adolescence | 1 | 2015 | 78 | 0.110 |
Why?
| | Multivariate Analysis | 5 | 2020 | 1504 | 0.110 |
Why?
| | Pneumonia | 2 | 1999 | 612 | 0.110 |
Why?
| | Life Style | 2 | 2015 | 459 | 0.110 |
Why?
| | Algorithms | 3 | 2017 | 1626 | 0.110 |
Why?
| | Health Services Accessibility | 2 | 2019 | 894 | 0.110 |
Why?
| | Qualitative Research | 1 | 2021 | 1192 | 0.110 |
Why?
| | Family Planning Services | 1 | 2015 | 81 | 0.110 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 778 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 339 | 0.110 |
Why?
| | Food Preferences | 1 | 2015 | 112 | 0.110 |
Why?
| | Bacterial Infections | 1 | 2016 | 236 | 0.110 |
Why?
| | Up-Regulation | 1 | 2017 | 848 | 0.110 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 615 | 0.110 |
Why?
| | Antibodies, Bacterial | 1 | 2014 | 137 | 0.110 |
Why?
| | Pennisetum | 1 | 2013 | 1 | 0.110 |
Why?
| | Hair | 3 | 2011 | 73 | 0.110 |
Why?
| | Acrodermatitis | 1 | 2013 | 1 | 0.110 |
Why?
| | Neonatology | 1 | 2013 | 22 | 0.110 |
Why?
| | Alkaline Phosphatase | 3 | 2011 | 148 | 0.110 |
Why?
| | Needs Assessment | 2 | 2015 | 360 | 0.110 |
Why?
| | Pregnancy, Multiple | 1 | 2013 | 15 | 0.110 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 258 | 0.110 |
Why?
| | Population Groups | 1 | 2013 | 60 | 0.110 |
Why?
| | Liver Diseases | 3 | 2013 | 284 | 0.110 |
Why?
| | Escherichia coli | 1 | 2017 | 782 | 0.110 |
Why?
| | Puerperal Disorders | 3 | 2020 | 30 | 0.100 |
Why?
| | Indicator Dilution Techniques | 4 | 2006 | 11 | 0.100 |
Why?
| | Iron Radioisotopes | 1 | 2012 | 4 | 0.100 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 542 | 0.100 |
Why?
| | Prolactin | 2 | 2007 | 99 | 0.100 |
Why?
| | Poverty Areas | 1 | 2012 | 35 | 0.100 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2012 | 29 | 0.100 |
Why?
| | Endocrine System | 1 | 2012 | 20 | 0.100 |
Why?
| | Urban Health | 1 | 2012 | 77 | 0.100 |
Why?
| | Clinical Competence | 1 | 2019 | 1020 | 0.100 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 61 | 0.100 |
Why?
| | Hospitals, University | 1 | 2012 | 177 | 0.100 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 61 | 0.100 |
Why?
| | Triglycerides | 1 | 2014 | 519 | 0.100 |
Why?
| | Intestine, Small | 2 | 2011 | 140 | 0.100 |
Why?
| | Obstetrics | 1 | 2013 | 159 | 0.090 |
Why?
| | Cerebrovascular Disorders | 1 | 2012 | 91 | 0.090 |
Why?
| | Analysis of Variance | 3 | 2002 | 1283 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 159 | 0.090 |
Why?
| | Erythrocyte Membrane | 1 | 2011 | 51 | 0.090 |
Why?
| | Curriculum | 3 | 2019 | 925 | 0.090 |
Why?
| | Chickens | 1 | 2011 | 187 | 0.090 |
Why?
| | International Agencies | 1 | 2011 | 29 | 0.090 |
Why?
| | Incidence | 4 | 2019 | 2634 | 0.090 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 4 | 1998 | 5 | 0.090 |
Why?
| | Digestive System | 2 | 2001 | 29 | 0.090 |
Why?
| | Single-Blind Method | 1 | 2011 | 273 | 0.090 |
Why?
| | Growth Charts | 1 | 2010 | 14 | 0.090 |
Why?
| | Interviews as Topic | 1 | 2014 | 696 | 0.090 |
Why?
| | Interleukin-6 | 1 | 2014 | 715 | 0.090 |
Why?
| | Dexamethasone | 1 | 2012 | 330 | 0.090 |
Why?
| | Inositol Phosphates | 1 | 2010 | 22 | 0.090 |
Why?
| | Language | 1 | 2013 | 283 | 0.090 |
Why?
| | Food, Formulated | 1 | 1989 | 16 | 0.080 |
Why?
| | Argentina | 3 | 2014 | 14 | 0.080 |
Why?
| | Physicians | 2 | 2019 | 846 | 0.080 |
Why?
| | Child Welfare | 1 | 2012 | 208 | 0.080 |
Why?
| | Family Nursing | 1 | 2009 | 13 | 0.080 |
Why?
| | Public Assistance | 1 | 2009 | 21 | 0.080 |
Why?
| | Manganese | 1 | 1989 | 61 | 0.080 |
Why?
| | Blood Glucose | 2 | 2021 | 2086 | 0.080 |
Why?
| | Program Evaluation | 1 | 2014 | 868 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1204 | 0.080 |
Why?
| | Mexico | 1 | 2009 | 189 | 0.080 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 764 | 0.080 |
Why?
| | Ascorbic Acid | 1 | 2009 | 120 | 0.080 |
Why?
| | Cattle | 2 | 2024 | 970 | 0.080 |
Why?
| | Patient Compliance | 1 | 2012 | 563 | 0.080 |
Why?
| | Urban Population | 3 | 2018 | 436 | 0.070 |
Why?
| | Celiac Disease | 1 | 2011 | 287 | 0.070 |
Why?
| | Congo | 2 | 2020 | 4 | 0.070 |
Why?
| | Safety | 1 | 2010 | 325 | 0.070 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 518 | 0.070 |
Why?
| | Health Planning Guidelines | 1 | 2007 | 25 | 0.070 |
Why?
| | Food Handling | 2 | 2025 | 61 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 594 | 0.070 |
Why?
| | Nutrition Disorders | 1 | 2007 | 23 | 0.070 |
Why?
| | Cognition | 2 | 2009 | 1093 | 0.070 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 57 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2421 | 0.070 |
Why?
| | Child Behavior | 1 | 2009 | 235 | 0.070 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1213 | 0.070 |
Why?
| | Aged | 3 | 2023 | 22035 | 0.070 |
Why?
| | Mutation | 2 | 2013 | 3671 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1840 | 0.070 |
Why?
| | Sex Factors | 2 | 2010 | 1947 | 0.070 |
Why?
| | Carrier Proteins | 2 | 2002 | 728 | 0.070 |
Why?
| | Injections, Intravenous | 3 | 2004 | 200 | 0.070 |
Why?
| | Research Design | 2 | 2019 | 1038 | 0.070 |
Why?
| | Caregivers | 1 | 2014 | 821 | 0.070 |
Why?
| | Proteins | 1 | 2012 | 945 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2011 | 722 | 0.060 |
Why?
| | Postprandial Period | 2 | 1997 | 103 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 77 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 48 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Energy Metabolism | 2 | 2015 | 837 | 0.060 |
Why?
| | Malaria, Falciparum | 1 | 2005 | 24 | 0.060 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 123 | 0.060 |
Why?
| | Obstetric Labor, Premature | 2 | 2016 | 35 | 0.060 |
Why?
| | Gastroplasty | 1 | 2004 | 29 | 0.060 |
Why?
| | Health Behavior | 2 | 2023 | 732 | 0.060 |
Why?
| | Schools | 1 | 2007 | 441 | 0.050 |
Why?
| | Zinc Radioisotopes | 1 | 2003 | 1 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5270 | 0.050 |
Why?
| | Delivery of Health Care | 2 | 2022 | 896 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 32 | 0.050 |
Why?
| | Home Childbirth | 2 | 2013 | 5 | 0.050 |
Why?
| | Neonatal Sepsis | 1 | 2023 | 3 | 0.050 |
Why?
| | Sodium Chloride, Dietary | 1 | 2023 | 36 | 0.050 |
Why?
| | Palm Oil | 1 | 2002 | 2 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 16 | 0.050 |
Why?
| | Sodium Chloride | 1 | 2023 | 141 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 74 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 287 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 81 | 0.050 |
Why?
| | Reference Standards | 1 | 2002 | 168 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2002 | 89 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 399 | 0.050 |
Why?
| | Circadian Rhythm | 1 | 1985 | 401 | 0.050 |
Why?
| | Community Health Services | 1 | 2023 | 224 | 0.050 |
Why?
| | Central America | 1 | 2020 | 21 | 0.050 |
Why?
| | Phospholipids | 1 | 2022 | 209 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 729 | 0.050 |
Why?
| | Magnesium | 2 | 2001 | 151 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2014 | 813 | 0.040 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 42 | 0.040 |
Why?
| | Selenium | 1 | 2020 | 37 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 2 | 2019 | 73 | 0.040 |
Why?
| | Orosomucoid | 1 | 2020 | 5 | 0.040 |
Why?
| | Metallothionein | 1 | 2000 | 24 | 0.040 |
Why?
| | Vaccination | 2 | 2022 | 1350 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 356 | 0.040 |
Why?
| | Child Abuse | 1 | 2005 | 518 | 0.040 |
Why?
| | Licensure | 1 | 2019 | 12 | 0.040 |
Why?
| | HIV Infections | 1 | 2014 | 2696 | 0.040 |
Why?
| | Nicaragua | 1 | 2019 | 7 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2767 | 0.040 |
Why?
| | Zinc Sulfate | 2 | 2012 | 8 | 0.040 |
Why?
| | Colombia | 1 | 2019 | 37 | 0.040 |
Why?
| | Puerto Rico | 1 | 2019 | 53 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 422 | 0.040 |
Why?
| | Peru | 1 | 2019 | 54 | 0.040 |
Why?
| | Hepatocytes | 1 | 2020 | 215 | 0.040 |
Why?
| | Accreditation | 1 | 2019 | 81 | 0.040 |
Why?
| | Brazil | 1 | 2019 | 100 | 0.040 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 102 | 0.040 |
Why?
| | Family Relations | 1 | 2000 | 89 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2019 | 79 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 20 | 0.040 |
Why?
| | Asia, Southeastern | 1 | 2018 | 11 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 34 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 1998 | 72 | 0.040 |
Why?
| | Zika Virus | 1 | 2019 | 76 | 0.040 |
Why?
| | Focus Groups | 1 | 2021 | 442 | 0.040 |
Why?
| | Rhinitis, Allergic | 1 | 2019 | 44 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2520 | 0.040 |
Why?
| | Spleen | 1 | 2020 | 518 | 0.040 |
Why?
| | Organ Specificity | 2 | 2014 | 296 | 0.040 |
Why?
| | Eczema | 1 | 2019 | 83 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 79 | 0.040 |
Why?
| | Microwaves | 1 | 1998 | 35 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2019 | 268 | 0.040 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 282 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 1019 | 0.040 |
Why?
| | Hospitals, Maternity | 1 | 2017 | 4 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2020 | 394 | 0.040 |
Why?
| | Tuberculosis | 1 | 2000 | 271 | 0.040 |
Why?
| | Food-Drug Interactions | 1 | 2017 | 8 | 0.040 |
Why?
| | Pressure | 1 | 1998 | 238 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 194 | 0.030 |
Why?
| | Fermentation | 1 | 2017 | 26 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 166 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2019 | 560 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 15 | 0.030 |
Why?
| | Chromatography, Gas | 1 | 2016 | 32 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 226 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 278 | 0.030 |
Why?
| | Kidney | 2 | 2020 | 1330 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 1997 | 249 | 0.030 |
Why?
| | Phosphates | 1 | 1997 | 168 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 25 | 0.030 |
Why?
| | Computer Simulation | 1 | 2000 | 943 | 0.030 |
Why?
| | Community Health Centers | 1 | 2016 | 58 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 109 | 0.030 |
Why?
| | RNA, Viral | 1 | 2019 | 622 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 370 | 0.030 |
Why?
| | Pancreas | 1 | 1998 | 307 | 0.030 |
Why?
| | Reproductive Behavior | 1 | 2015 | 10 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 598 | 0.030 |
Why?
| | Students, Medical | 1 | 2019 | 305 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1967 | 0.030 |
Why?
| | Dermatitis, Atopic | 1 | 2019 | 335 | 0.030 |
Why?
| | Dental Caries | 1 | 2016 | 157 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1694 | 0.030 |
Why?
| | Medical History Taking | 1 | 1995 | 119 | 0.030 |
Why?
| | Absorption, Physiological | 1 | 2014 | 4 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2020 | 570 | 0.030 |
Why?
| | Vaccines, Conjugate | 1 | 2014 | 63 | 0.030 |
Why?
| | Fetal Proteins | 1 | 1994 | 16 | 0.030 |
Why?
| | Insulin-Like Growth Factor II | 1 | 1994 | 25 | 0.030 |
Why?
| | Patient Care Planning | 1 | 2015 | 152 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 286 | 0.030 |
Why?
| | Bacteria | 1 | 2020 | 812 | 0.030 |
Why?
| | Kinetics | 3 | 2007 | 1619 | 0.030 |
Why?
| | Ferrous Compounds | 2 | 2005 | 23 | 0.030 |
Why?
| | Serum Albumin | 3 | 1999 | 145 | 0.030 |
Why?
| | Health | 1 | 2014 | 74 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2014 | 295 | 0.030 |
Why?
| | Estradiol | 1 | 1997 | 494 | 0.030 |
Why?
| | Amino Acids | 1 | 1997 | 469 | 0.030 |
Why?
| | Maternal-Fetal Exchange | 1 | 2014 | 159 | 0.030 |
Why?
| | Contraception | 1 | 2015 | 142 | 0.030 |
Why?
| | Physical Examination | 1 | 1995 | 237 | 0.030 |
Why?
| | Uruguay | 1 | 2013 | 1 | 0.030 |
Why?
| | Pregnancy, Twin | 1 | 2013 | 17 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 301 | 0.030 |
Why?
| | Hypertension | 2 | 2016 | 1236 | 0.030 |
Why?
| | Fetal Mortality | 1 | 2012 | 2 | 0.030 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2012 | 35 | 0.030 |
Why?
| | DNA Replication | 1 | 1994 | 225 | 0.020 |
Why?
| | Minerals | 1 | 2012 | 38 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1002 | 0.020 |
Why?
| | South Australia | 1 | 2011 | 2 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 121 | 0.020 |
Why?
| | Healthy Volunteers | 1 | 2012 | 204 | 0.020 |
Why?
| | Liver Transplantation | 1 | 1999 | 800 | 0.020 |
Why?
| | Breath Tests | 1 | 2011 | 91 | 0.020 |
Why?
| | Sucrose | 1 | 2011 | 93 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 106 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 255 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2011 | 121 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 338 | 0.020 |
Why?
| | Risk | 1 | 2013 | 866 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 485 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2012 | 550 | 0.020 |
Why?
| | Protein Deficiency | 1 | 2007 | 3 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1093 | 0.020 |
Why?
| | Lung | 1 | 2020 | 3925 | 0.020 |
Why?
| | Counseling | 1 | 2010 | 382 | 0.020 |
Why?
| | Blood Transfusion | 1 | 1989 | 294 | 0.020 |
Why?
| | Self Efficacy | 1 | 2010 | 377 | 0.020 |
Why?
| | Food, Genetically Modified | 1 | 2006 | 3 | 0.020 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2006 | 26 | 0.020 |
Why?
| | Plants, Genetically Modified | 1 | 2006 | 19 | 0.020 |
Why?
| | Biliary Atresia | 1 | 1987 | 160 | 0.020 |
Why?
| | Sweat | 1 | 1986 | 46 | 0.020 |
Why?
| | Asthma | 1 | 2019 | 2258 | 0.020 |
Why?
| | Antimalarials | 1 | 2005 | 30 | 0.020 |
Why?
| | Gallstones | 1 | 2005 | 30 | 0.020 |
Why?
| | Chloroquine | 1 | 2005 | 52 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 203 | 0.010 |
Why?
| | Isotope Labeling | 1 | 2005 | 73 | 0.010 |
Why?
| | Mental Competency | 1 | 2004 | 28 | 0.010 |
Why?
| | Parental Consent | 1 | 2004 | 26 | 0.010 |
Why?
| | Anorexia | 1 | 1984 | 19 | 0.010 |
Why?
| | Family Characteristics | 1 | 2005 | 175 | 0.010 |
Why?
| | Primary Prevention | 1 | 2005 | 191 | 0.010 |
Why?
| | Informed Consent | 1 | 2004 | 180 | 0.010 |
Why?
| | Models, Statistical | 1 | 2007 | 626 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2005 | 252 | 0.010 |
Why?
| | Mass Screening | 1 | 2010 | 1121 | 0.010 |
Why?
| | Gastrointestinal Transit | 1 | 2002 | 7 | 0.010 |
Why?
| | Body Fluid Compartments | 1 | 2002 | 6 | 0.010 |
Why?
| | Mice | 1 | 2018 | 16543 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 185 | 0.010 |
Why?
| | Free Radicals | 1 | 2001 | 102 | 0.010 |
Why?
| | Radioactive Tracers | 1 | 2000 | 3 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 50 | 0.010 |
Why?
| | Phosphorus | 1 | 2001 | 92 | 0.010 |
Why?
| | Urine | 1 | 2000 | 56 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 671 | 0.010 |
Why?
| | Blood | 1 | 2000 | 99 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 7050 | 0.010 |
Why?
| | Diabetes Complications | 1 | 2001 | 227 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2004 | 734 | 0.010 |
Why?
| | Eating | 1 | 2000 | 366 | 0.010 |
Why?
| | Postoperative Period | 1 | 1999 | 319 | 0.010 |
Why?
| | Creatinine | 1 | 1999 | 485 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 978 | 0.010 |
Why?
| | Software | 1 | 2000 | 611 | 0.010 |
Why?
| | Europe | 1 | 1995 | 366 | 0.010 |
Why?
| | North America | 1 | 1995 | 289 | 0.010 |
Why?
| | Chronic Disease | 1 | 1999 | 1715 | 0.010 |
Why?
| | Sheep | 1 | 1994 | 832 | 0.010 |
Why?
| | Urinary Tract Infections | 1 | 1989 | 144 | 0.000 |
Why?
| | Erythrocyte Transfusion | 1 | 1989 | 185 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1994 | 2700 | 0.000 |
Why?
| | Cells, Cultured | 1 | 1994 | 4048 | 0.000 |
Why?
| | Surgical Wound Infection | 1 | 1989 | 291 | 0.000 |
Why?
| | Saliva | 1 | 1983 | 204 | 0.000 |
Why?
| | Blood Proteins | 1 | 1983 | 233 | 0.000 |
Why?
|
|
Krebs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|